Date Action Amount Person Type
Sep 01, 2022 Buy 58 000 Buck Kristen K Common Stock
Sep 01, 2022 Sell 44 776 Buck Kristen K Common Stock
Sep 01, 2022 Buy 150 000 Mazzo David J Common Stock
Sep 01, 2022 Sell 69 742 Mazzo David J Common Stock
Jan 14, 2022 Sell 6 611 Mazzo David J Common Stock
Jan 13, 2022 Sell 6 471 Mazzo David J Common Stock
Jan 11, 2022 Sell 16 740 Mazzo David J Common Stock
Jan 10, 2022 Buy 401 000 Mazzo David J Common Stock
Jan 10, 2022 Sell 56 410 Mazzo David J Common Stock
Jan 10, 2022 Buy 200 000 Mazzo David J Stock Option (Right to Buy)
Jan 10, 2022 Buy 65 430 Whitaker Anne Clem Common Stock
Jan 10, 2022 Buy 65 430 Traber Peter G Common Stock
Jan 10, 2022 Buy 65 430 Myers Steven S Common Stock
Jan 10, 2022 Buy 65 430 Klosk Steven M Common Stock
Jan 10, 2022 Buy 65 430 Davidson Michael H. Common Stock
Jan 10, 2022 Buy 65 430 Brown Gregory B Common Stock
Dec 08, 2021 Buy 33 785 Myers Steven S Common Stock
Sep 01, 2021 Buy 0 Buck Kristen K
Jun 17, 2021 Buy 0 Girolamo Todd C
Jan 14, 2021 Sell 5 936 Mazzo David J Common Stock
Jan 13, 2021 Buy 39 000 Mazzo David J Common Stock
Jan 13, 2021 Sell 21 787 Mazzo David J Common Stock
Jan 13, 2021 Sell 6 425 Mazzo David J Common Stock
Jan 11, 2021 Buy 37 735 Whitaker Anne Clem Common Stock
Jan 11, 2021 Buy 37 735 Traber Peter G Common Stock
Jan 11, 2021 Buy 37 735 Schwalm Cynthia Common Stock
Jan 11, 2021 Buy 37 735 Myers Steven S Common Stock
Jan 11, 2021 Buy 37 735 Klosk Steven M Common Stock
Jan 11, 2021 Buy 37 735 Davidson Michael H. Common Stock
Jan 11, 2021 Buy 37 735 Brown Gregory B Common Stock
Jan 11, 2021 Buy 119 000 Mazzo David J Common Stock
Jan 11, 2021 Sell 16 621 Mazzo David J Common Stock
Jan 11, 2021 Buy 60 000 Mazzo David J Stock Options (Right to Buy)
Jan 08, 2021 Sell 4 726 Mazzo David J Common Stock
Nov 01, 2020 Buy 79 470 Whitaker Anne Clem Common Stock
Nov 01, 2020 Buy 0 Whitaker Anne Clem
Sep 09, 2020 Buy 55 525 Davidson Michael H. Common Stock
Jul 28, 2020 Buy 51 063 Davidson Michael H. Common Stock
Jul 28, 2020 Buy 0 Davidson Michael H.
Jan 14, 2020 Sell 2 190 Talamo Joseph Common Stock
Jan 14, 2020 Sell 6 382 Mazzo David J Common Stock
Jan 14, 2020 Sell 2 190 Losordo Douglas W Common Stock
Jan 13, 2020 Buy 19 000 Talamo Joseph Common Stock
Jan 13, 2020 Sell 2 601 Talamo Joseph Common Stock
Jan 13, 2020 Buy 29 000 Talamo Joseph Stock Options (Right to Buy)
Jan 13, 2020 Buy 46 000 Mazzo David J Common Stock
Jan 13, 2020 Sell 6 246 Mazzo David J Common Stock
Jan 13, 2020 Buy 69 000 Mazzo David J Stock Options (Right to Buy)
Jan 13, 2020 Buy 19 000 Losordo Douglas W Common Stock
Jan 13, 2020 Sell 2 601 Losordo Douglas W Common Stock
Jan 13, 2020 Buy 29 000 Losordo Douglas W Stock Options (Right to Buy)
Jan 13, 2020 Buy 18 292 Traber Peter G Restricted Stock Units
Jan 13, 2020 Buy 18 292 Schwalm Cynthia Restricted Stock Units
Jan 13, 2020 Buy 18 292 Myers Steven S Restricted Stock Units
Jan 13, 2020 Buy 18 292 Klosk Steven M Restricted Stock Units
Jan 13, 2020 Buy 18 292 Brown Gregory B Restricted Stock Units
Jan 08, 2020 Sell 1 821 Talamo Joseph Common Stock
Jan 08, 2020 Sell 4 522 Mazzo David J Common Stock
Jan 08, 2020 Sell 1 821 Losordo Douglas W Common Stock
Jan 14, 2019 Buy 16 000 Talamo Joseph Common Stock
Jan 14, 2019 Sell 2 159 Talamo Joseph Common Stock
Jan 14, 2019 Buy 24 000 Talamo Joseph Stock Options (Right to Buy)
Jan 14, 2019 Buy 47 000 Mazzo David J Common Stock
Jan 14, 2019 Sell 6 301 Mazzo David J Common Stock
Jan 14, 2019 Buy 71 000 Mazzo David J Stock Options (Right to Buy)
Jan 14, 2019 Buy 16 000 Losordo Douglas W Common Stock
Jan 14, 2019 Sell 2 159 Losordo Douglas W Common Stock
Jan 14, 2019 Buy 24 000 Losordo Douglas W Stock Options (Right to Buy)
Jan 14, 2019 Buy 12 121 Traber Peter G Restricted Stock Units
Jan 14, 2019 Buy 12 121 Schwalm Cynthia Restricted Stock Units
Jan 14, 2019 Buy 12 121 Myers Steven S Restricted Stock Units
Jan 14, 2019 Buy 12 121 Klosk Steven M Restricted Stock Units
Jan 14, 2019 Buy 12 121 Brown Gregory B Restricted Stock Units
Jan 08, 2019 Sell 1 795 Talamo Joseph Common Stock
Jan 08, 2019 Sell 4 478 Mazzo David J Common Stock
Jan 08, 2019 Sell 1 795 Losordo Douglas W Common Stock
Jan 08, 2019 Buy 8 747 Traber Peter G Common Stock
Jan 08, 2019 Buy 8 747 Myers Steven S Common Stock
Jan 08, 2019 Buy 8 747 Klosk Steven M Common Stock
Jan 08, 2019 Buy 8 747 Brown Gregory B Common Stock
Nov 07, 2018 Buy 12 269 Schwalm Cynthia Restricted Stock Units
Nov 07, 2018 Buy 0 Schwalm Cynthia
Jun 20, 2018 Buy 13 300 Talamo Joseph Common Stock
Jun 20, 2018 Sell 6 407 Talamo Joseph Common Stock
Jun 20, 2018 Buy 13 300 Losordo Douglas W Common Stock
Jun 20, 2018 Sell 6 407 Losordo Douglas W Common Stock
Jun 20, 2018 Buy 33 300 Mazzo David J Common Stock
Jun 20, 2018 Sell 16 091 Mazzo David J Common Stock
Apr 06, 2018 Buy 13 300 Losordo Douglas W Performance Rights
Apr 06, 2018 Buy 33 300 Mazzo David J Performance Rights
Apr 06, 2018 Buy 13 300 Talamo Joseph Performance Rights
Jan 08, 2018 Buy 13 300 Losordo Douglas W Common Stock
Jan 08, 2018 Sell 1 803 Losordo Douglas W Common Stock
Jan 08, 2018 Buy 20 000 Losordo Douglas W Stock Option
Jan 08, 2018 Buy 33 300 Mazzo David J Common Stock
Jan 08, 2018 Sell 4 462 Mazzo David J Common Stock
Jan 08, 2018 Buy 50 000 Mazzo David J Stock Option
Jan 08, 2018 Buy 13 300 Talamo Joseph Common Stock
Jan 08, 2018 Sell 1 803 Talamo Joseph Common Stock
Jan 08, 2018 Buy 20 000 Talamo Joseph Stock Option
INSIDER POWER
6.780
Last 100 transactions
Buy: 2 781 590 | Sell: 342 279 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 6.780.

In total, the insiders bought 2 781 590 and sold 342 279 CLBS shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Caladrius Biosciences

Caladrius Biosciences Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysf... CLBS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT